ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1064

Inpatient and Outpatient Palliative Care Referral Practices for Patients with Rheumatic Disease: Retrospective Chart Review at a Single Academic Medical Center

Shannon Herndon1, Jack Kimball1 and David Leverenz2, 1Duke University Medical Center, Durham, NC, 2Duke University, Durham, NC

Meeting: ACR Convergence 2024

Keywords: Aging, Disability, pain, quality of life

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Measures & Measurement of Healthcare Quality Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Palliative medicine prioritizes quality of life and relief of suffering in serious illness. Despite high morbidity and mortality in rheumatic disease, data suggests that palliative care (PC) remains underutilized. In this study, we sought to analyze the current inpatient and outpatient referral practices to PC for patients with rheumatic disease at a single academic institution.

Methods: A medical records extraction tool was used to identify eligible patients for retrospective chart review. First, all patients seen at our institution’s outpatient rheumatology clinics over the preceding 5 years were filtered by referral to ambulatory PC from rheumatology clinic. Next, all patients seen by the inpatient rheumatology consult team over the preceding 1 year were filtered by co-consultation of inpatient PC. Inpatients were excluded if the reason for rheumatology consultation ended up not being for a true rheumatic reason. Chart review was performed on these patients to identify demographics, rheumatic diagnosis, prior Advance Care Planning (ACP), reason for referral, outcome of referral, and cause of death if applicable. For inpatient consults, factors also included reason for inpatient rheumatology consultation and if rheumatology-initiated PC consultation. Data analysis was performed using descriptive statistics.

Results: Of the 18,441 patients seen in rheumatology clinics over the preceding 5 years, 11 (0.06%) were referred to ambulatory PC. Of the 527 inpatients seen by rheumatology over the preceding 1 year, 29 (6%) were also seen by inpatient PC consultants. 15 were excluded, resulting in 14 out of 527 (3%) inpatients. Patient characteristics are shown in Table 1. Of inpatients, most had a prior rheumatic diagnosis at time of consult (n=12, 86%). Reasons for consultation are shown in Figure 1. Only 1 outpatient (9%) and 1 inpatient (7%) had prior ACP before seeing PC. Rarely was inpatient PC referral initiated by rheumatology (n=2, 14%). Nearly half of outpatients (n=5, 45%) were deceased by the time of chart review; average time of death following referral was 190 days [76-478] (Figure 2). No inpatients died during hospitalization and 7 (50%) were deceased at the time of chart review; average time of death following hospitalization was 139 days [1-332].

Conclusion: Data from our academic institution demonstrates that patients with rheumatic disease are rarely referred to PC and rates of ACP are low. When PC referral does occur, mortality for these patients is high, perhaps due to late timing of referral. Patients seen by PC have a wide spectrum of age and underlying rheumatic diagnosis. Similarly, the reason for PC involvement varies among patients. Rheumatic disease contributes substantially to mortality when death occurs. Further research is needed to better define the need for earlier and more frequent identification of patients appropriate for referral to PC.

Supporting image 1

Table 1. Patient characteristics, including demographic factors and diagnoses, by inpatient and outpatient palliative care consultation.

Supporting image 2

Figure 1. Reason for palliative care consultation, by percent of total consultations, shown by color for outpatient and inpatient consultation of palliative care.

Supporting image 3

Figure 2. Left: patient condition (alive or deceased) at time of chart review. Right: causes of death, with the primary disease attributed to cause of death shown by percentage of total deaths for that group (outpatient or inpatient).


Disclosures: S. Herndon: Aurinia, 5, Rheumatology Research Foundation, 5; J. Kimball: None; D. Leverenz: Pfizer, 5, Rheumatology Research Foundation, 5, Sanofi, 2, UCB, 2.

To cite this abstract in AMA style:

Herndon S, Kimball J, Leverenz D. Inpatient and Outpatient Palliative Care Referral Practices for Patients with Rheumatic Disease: Retrospective Chart Review at a Single Academic Medical Center [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/inpatient-and-outpatient-palliative-care-referral-practices-for-patients-with-rheumatic-disease-retrospective-chart-review-at-a-single-academic-medical-center/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inpatient-and-outpatient-palliative-care-referral-practices-for-patients-with-rheumatic-disease-retrospective-chart-review-at-a-single-academic-medical-center/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology